Highest-materiality recent filing
HealthLynked issues $5.7M secured convertible note to CEO's trust at 12%, convertible at $4.25
Principal $5,715,811.98 to Mary S. Dent Gifting Trust (controlled by CEO Dr. Michael Dent).
HealthLynked appoints COO and adds two directors; targets Nasdaq uplist in 2026
Duncan McGillivray appointed COO effective Dec 8, 2025; base salary $120K/yr, rising to $150K on Nasdaq uplist.
HealthLynked issues $420K convertible note to CEO's trust; extends $1.22M in notes
Issued $420,000 convertible promissory note to Mary S. Dent Gifting Trust, controlled by CEO Dr. Michael Dent, to replace undocumented advances from Sep-Nov 2024.
HealthLynked issues $900K convertible notes at 12% with warrant to CEO's trust
Aggregate principal $900,000, net proceeds $855,000 after 5% OID; issued in 10 tranches from July to Sept 2024.
HealthLynked CEO Dr. Michael Dent provides $1M convertible note financing via trust
Issued $1M senior secured convertible note to Mary S. Dent Gifting Trust (CEO-controlled) on June 3, 2024.
HealthLynked sells ACO Health Partners to PBACO for up to $3M cash plus up to $7M in IPO shares
$750K cash at signing; up to $2.25M incremental cash based on physician participation by July 31, 2023.
HealthLynked issues $550K promissory note to Yorkville with 5% OID, 5-month maturity
Note issued July 19, 2022 to YA II PN, Ltd.; net proceeds ~$522,500 after 5% OID.
HealthLynked enters equity line for up to 30M shares; issues 895K commitment shares to Yorkville
Standby Equity Purchase Agreement with YA II PN allows sale of up to 30M shares at 96% of Market Price.
Effective January 15, 2025, HealthLynked Corp., a Nevada corporation (the “ Company ”), appointed Jeremy Daniel, age 48, as its part-time Chief Financial Officer, effective immediately.
Effective January 15, 2025, David Rosal tendered his resignation as Chief Financial Officer of the Company.
On June 25, 2024, HealthLynked Corp., a Nevada corporation (the “ Company ”), appointed William Crupi, age 35, as its Chief Operating Officer, effective immediately.
appointed David Rosal, age 61, as its Chief Financial Officer, effective immediately.
On January 5, 2024, George O'Leary tendered his resignation as Chief Financial Officer of HealthLynked Corp., a Nevada corporation (the “ Company ”) effective April 4, 2024.
On March 13, 2023, the Board appointed Paul J. Hobaica, M.D. as a director of the Company, effective immediately, to fill the vacancy created by Robert Mino’s resignation.
On March 13, 2023, the Board of Directors (the “ Board ”) of HealthLynked Corp., a Nevada corporation (the “ Company ”) accepted independent director Robert Mino’s resignation, effective immediately.
Max materiality 0.65 · Median 0.55 · Most common event debt